Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Update

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 15,100 shares, a decrease of 52.8% from the January 31st total of 32,000 shares. Based on an average daily trading volume, of 70,200 shares, the short-interest ratio is presently 0.2 days.

Ocean Biomedical Price Performance

Shares of NASDAQ:OCEAW traded down $0.00 on Friday, reaching $0.03. The company’s stock had a trading volume of 25,861 shares, compared to its average volume of 100,407. The stock’s 50-day moving average is $0.03 and its two-hundred day moving average is $0.04. Ocean Biomedical has a 52-week low of $0.02 and a 52-week high of $0.70.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.